Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK

Author： Adis International Limited

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.7, 2005-01, pp. : 743-743

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis

By Jansen Jeroen P.

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 323-344

Adis International

Access to resources Recommend Favorite

Use and costs of anti-secretory and cardiovascular co-medication in osteoarthritis patients treated with selective or non-selective NSAIDS

By Simoens Steven Coster Sandra Ruyck Bernard Stutz Petra Laekeman Gert

Pharmacy World and Science, Vol. 28, Iss. 5, 2006-10 ,pp. : 309-317

Springer Publishing Company

Access to resources Recommend Favorite

Etoricoxib: A Review of its Use in the Symptomatic Treatment of Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis and Acute Gouty Arthritis

By Croom Katherine F. Siddiqui M. Asif A.

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1513-1532

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Nimesulide Versus Diclofenac in the Treatment of Osteoarthritis in Greece

By Liaropoulos L.

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 575-588

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Nimesulide versus Diclofenac in the Treatment of Osteoarthritis in France, Italy and Spain

By Tarricone R.

Clinical Drug Investigation, Vol. 21, Iss. 7, 2001-07 ,pp. : 453-464

Adis International

Access to resources Recommend Favorite